Schedule 13G ownership disclosure

Ampio Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 03209T109

Event date: 2019-06-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,750,000
Percent of class
6.1900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000090
Form type
SC 13G
Filer
Ampio Pharmaceuticals, Inc.
CIK
CIK 1411906
Filed
Jun 17, 2019
Reporting period
Jun 17, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub